Hasil Pencarian - Axel Haferkamp

Perbaiki Hasil
  1. 1
    Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomy

    Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomy oleh Stephan Buse, Assen Alexandrov, Elio Mazzone, Alexandre Mottrie, Axel Haferkamp

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Impact of Blood Loss on Renal Function and Interaction with Ischemia Duration after Nephron-Sparing Surgery

    Impact of Blood Loss on Renal Function and Interaction with Ischemia Duration after Nephron-Sparing Surgery oleh Stephan Buse, René Mager, Elio Mazzone, Alexandre Mottrie, Sebastian Frees, Axel Haferkamp

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation

    Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation oleh Gregor Duwe, Nikita Dhruva Fischer, Maximilian Haack, Thomas Höfner, Axel Haferkamp, Maximilian Peter Brandt

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Publication of original research in urologic journals--a neglected orphan?

    Publication of original research in urologic journals--a neglected orphan? oleh Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Axel Haferkamp, Roman A Blaheta

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.

    Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo. oleh Eva Juengel, Jasmina Makarević, Igor Tsaur, Georg Bartsch, Karen Nelson, Axel Haferkamp, Roman A Blaheta

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

    Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned oleh Christian Thomas, Georg Bartsch, Christian Walter, Hendrik Borgmann, Maximilian Peter Brandt, Thomas Höfner, Axel Haferkamp, Igor Tsaur

    Diterbitkan 2016-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.

    PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target. oleh Holger Hans Hermann Erb, Marlies Ebert, Ronja Kuhn, Lukas Donix, Axel Haferkamp, Robert Ian Seed, Eva Jüngel

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    I publish in I edit?--Do editorial board members of urologic journals preferentially publish their own scientific work?

    I publish in I edit?--Do editorial board members of urologic journals preferentially publish their own scientific work? oleh Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Georg Bartsch, Axel Haferkamp, Roman A Blaheta

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

    Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism oleh Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta

    Diterbitkan 2014-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Amygdalin influences bladder cancer cell adhesion and invasion in vitro.

    Amygdalin influences bladder cancer cell adhesion and invasion in vitro. oleh Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Igor Tsaur, Karen Nelson, Jesco Pfitzenmaier, Axel Haferkamp, Roman A Blaheta

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2.

    Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2. oleh Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A Blaheta

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction

    Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction oleh Fuguang Zhao, Olesya Vakhrusheva, Sascha D. Markowitsch, Kimberly S. Slade, Igor Tsaur, Jindrich Cinatl, Martin Michaelis, Thomas Efferth, Axel Haferkamp, Eva Juengel

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology

    Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology oleh Gregor Duwe, Dominique Mercier, Crispin Wiesmann, Verena Kauth, Kerstin Moench, Markus Junker, Christopher C. M. Neumann, Axel Haferkamp, Andreas Dengel, Thomas Höfner

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models

    Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models oleh Maximilian Haack, Katja Reisen, Ahmed Ghazy, Kristina Stroh, Lisa Frey, Peter Sparwasser, Gregor Duwe, Rene Mager, Axel Haferkamp, Hendrik Borgmann, Hendrik Borgmann

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics

    Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics oleh Stefan Vallo, Martin Michaelis, Florian Rothweiler, Georg Bartsch, Kilian M. Gust, Dominik M. Limbart, Franz Rödel, Felix Wezel, Axel Haferkamp, Jindrich Cinatl, Jr

    Diterbitkan 2015-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content.

    Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content. oleh Johannes Salem, Hendrik Borgmann, Matthew Bultitude, Hans-Martin Fritsche, Axel Haferkamp, Axel Heidenreich, Arkadiusz Miernik, Andreas Neisius, Thomas Knoll, Christian Thomas, Igor Tsaur

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer

    Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer oleh Stephan Macher-Goeppinger, Sebastian Aulmann, Nina Wagener, Benjamin Funke, Katrin E. Tagscherer, Axel Haferkamp, Markus Hohenfellner, Sunghee Kim, Frank Autschbach, Peter Schirmacher, Wilfried Roth

    Diterbitkan 2008-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer

    Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer oleh Igor Tsaur, Carmen Biegel, Kilian Gust, Tanja Huesch, Hendrik Borgmann, Maximilian P.J.K. Brandt, Martin Kurosch, Michael Reiter, Georg Bartsch, David Schilling, Axel Haferkamp

    Diterbitkan 2015-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro

    Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro oleh Hui Xie, Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Anita Thomas, Eva Juengel, Felix K.-H. Chun, Jindrich Cinatl, Axel Haferkamp, Igor Tsaur, Roman A. Blaheta

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients

    Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients oleh Sascha D. Markowitsch, Sali Binali, Jochen Rutz, Felix K.-H. Chun, Axel Haferkamp, Igor Tsaur, Eva Juengel, Nikita D. Fischer, Anita Thomas, Roman A. Blaheta

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: